Amyris, a synthetic biotechnology company accelerating the world's transition to sustainable consumption, completed the acquisition of MenoLabs, a company founded by women to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause. Financial terms were not disclosed. "We are very impressed with the MenoLabs offering which is synergistic with our science-based approach to real-world health and wellness issues. We are committed to empowering women and creating a platform to support them with our leading science and wellness technology platform. Women deserve products and solutions that work during this period in their lives," John Melo, Amyris President and CEO.